Adial Pharmaceuticals, Inc.
ADIL
$0.33
$0.013.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.61M | 5.92M | 2.37M | 3.75M | 5.20M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 407.50K | 163.60K | 263.40K | 308.20K | 409.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 4.40K |
| Total Current Assets | 5.01M | 6.08M | 2.63M | 4.06M | 5.62M |
|
|
|||||
| Total Current Assets | 5.01M | 6.08M | 2.63M | 4.06M | 5.62M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.90K | 3.10K | 3.20K | 3.30K | 3.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.66M | 6.80M | 3.45M | 5.04M | 6.71M |
|
|
|||||
| Total Accounts Payable | 556.30K | 671.10K | 565.80K | 298.40K | 318.10K |
| Total Accrued Expenses | 598.50K | 539.90K | 758.70K | 677.50K | 510.90K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.15M | 1.21M | 1.32M | 975.90K | 829.00K |
|
|
|||||
| Total Current Liabilities | 1.15M | 1.21M | 1.32M | 975.90K | 829.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.15M | 1.21M | 1.32M | 975.90K | 829.00K |
|
|
|||||
| Common Stock & APIC | 92.48M | 91.77M | 86.35M | 86.06M | 85.81M |
| Retained Earnings | -87.98M | -86.18M | -84.22M | -82.00M | -79.92M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.51M | 5.59M | 2.13M | 4.07M | 5.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.51M | 5.59M | 2.13M | 4.07M | 5.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.51M | 5.59M | 2.13M | 4.07M | 5.88M |
|
|
|||||